{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:36Z","timestamp":1761895836420},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T00:00:00Z","timestamp":1394668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1758-5996-6-37","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T04:02:20Z","timestamp":1394683340000},"source":"Crossref","is-referenced-by-count":11,"title":["Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes"],"prefix":"10.1186","volume":"6","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-juan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-dong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-hang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,13]]},"reference":[{"key":"411_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009, 32: 193-203. 10.2337\/dc08-9025.","journal-title":"Diabetes Care"},{"key":"411_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00003495-200666010-00003","volume":"66","author":"AJ Garber","year":"2006","unstructured":"Garber AJ: Premixed insulin analogues for the treatment of diabetes mellitus. Drugs. 2006, 66: 31-49.","journal-title":"Drugs"},{"key":"411_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","volume":"24","author":"A Ceriello","year":"2004","unstructured":"Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004, 24: 816-823. 10.1161\/01.ATV.0000122852.22604.78.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"411_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jdiacomp.2004.10.001","volume":"19","author":"IB Hirsh","year":"2005","unstructured":"Hirsh IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control?. J Diabet Complications. 2005, 19: 178-181. 10.1016\/j.jdiacomp.2004.10.001.","journal-title":"J Diabet Complications"},{"key":"411_CR5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/j.1742-1241.2007.01598.x","volume":"61","author":"H Hammer","year":"2007","unstructured":"Hammer H, Klinge A: Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice. Int J Pract. 2007, 61: 2009-2018. 10.1111\/j.1742-1241.2007.01598.x.","journal-title":"Int J Pract"},{"key":"411_CR6","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","volume":"26","author":"MC Riddle","year":"2003","unstructured":"Riddle MC, Rosenstock J, Gerich J: Insulin Glargine 4002 Study Investigators: the treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003, 26: 3080-3086. 10.2337\/diacare.26.11.3080.","journal-title":"Diabetes Care"},{"key":"411_CR7","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","volume":"28","author":"M Peyrot","year":"2005","unstructured":"Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L, International DAWN Advisory Panel: Resistance to insulin therapy among patients and providers: results of the crossnational Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005, 28: 2673-2679. 10.2337\/diacare.28.11.2673.","journal-title":"Diabetes Care"},{"key":"411_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1177\/0145721709345773","volume":"35","author":"RR Rubin","year":"2009","unstructured":"Rubin RR, Peyrot M, Kruger DF, Travis LB: Barriers to insulin injection therapy: patient and health care provider perspectives. Diabetes Educ. 2009, 35: 1014-1022. 10.1177\/0145721709345773.","journal-title":"Diabetes Educ"},{"key":"411_CR9","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.2337\/diacare.28.10.2543","volume":"28","author":"WH Polonsky","year":"2005","unstructured":"Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care. 2005, 28: 2543-2545. 10.2337\/diacare.28.10.2543.","journal-title":"Diabetes Care"},{"key":"411_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4158\/EP.15.6.540","volume":"15","author":"HW Rodbard","year":"2009","unstructured":"Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS: Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009, 15: 540-559. 10.4158\/EP.15.6.540.","journal-title":"Endocr Pract"},{"key":"411_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","volume":"52","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association; European Association for the Study of Diabetes: Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009, 52: 17-30. 10.1007\/s00125-008-1157-y.","journal-title":"Diabetologia"},{"key":"411_CR12","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa075392","volume":"357","author":"RR Holman","year":"2007","unstructured":"Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC, 4-T Study Group: Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007, 357: 1716-1730. 10.1056\/NEJMoa075392.","journal-title":"N Engl J Med"},{"key":"411_CR13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1056\/NEJMoa0905479","volume":"361","author":"RR Holman","year":"2009","unstructured":"Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK, 4-T Study Group: Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009, 361: 1736-1747. 10.1056\/NEJMoa0905479.","journal-title":"N Engl J Med"},{"key":"411_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2337\/diacare.28.2.254","volume":"28","author":"HU Janka","year":"2005","unstructured":"Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-J\u00e4rvinen H: Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care. 2005, 28: 254-259. 10.2337\/diacare.28.2.254.","journal-title":"Diabetes Care"},{"key":"411_CR15","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1007\/s00125-009-1468-7","volume":"52","author":"DS Lasserson","year":"2009","unstructured":"Lasserson DS, Glasziou P, Perera R, Holman RR, Farmer AJ: Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia. 2009, 52: 1990-2000. 10.1007\/s00125-009-1468-7.","journal-title":"Diabetologia"},{"key":"411_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00125-005-0132-0","volume":"49","author":"H Yki-J\u00e4rvinen","year":"2006","unstructured":"Yki-J\u00e4rvinen H, Kauppinen-M\u00e4kelin R, Tiikkainen M, V\u00e4h\u00e4talo M, Virtamo H, Nikkil\u00e4 K, Tulokas T, Hulme S, Hardy K, McNulty S, H\u00e4nninen J, Lev\u00e4nen H, Lahdenper\u00e4 S, Lehtonen R, Ryysy L: Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia. 2006, 49: 442-451. 10.1007\/s00125-005-0132-0.","journal-title":"Diabetologia"},{"key":"411_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","volume":"45","author":"PE Cryer","year":"2002","unstructured":"Cryer PE: Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002, 45: 937-848. 10.1007\/s00125-002-0822-9.","journal-title":"Diabetologia"},{"key":"411_CR18","first-page":"503","volume":"20","author":"RJ McCrimmon","year":"1994","unstructured":"McCrimmon RJ, Frier BM: Hypoglycaemia, the most feared complication of insulin therapy. Diabete Metab. 1994, 20: 503-512.","journal-title":"Diabete Metab"},{"key":"411_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2337\/diacare.26.3.881","volume":"26","author":"L Monnier","year":"2003","unstructured":"Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003, 26: 881-885. 10.2337\/diacare.26.3.881.","journal-title":"Diabetes Care"},{"key":"411_CR20","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.2337\/dc08-s241","volume":"31","author":"L Monnier","year":"2008","unstructured":"Monnier L, Colette C: Glycemic variability: should we and can we prevent it?. Diabetes Care. 2008, 31: S150-S154. 10.2337\/dc08-s241.","journal-title":"Diabetes Care"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-5996-6-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1758-5996-6-37\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-5996-6-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:44:40Z","timestamp":1548215080000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/1758-5996-6-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1186\/1758-5996-6-37","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,13]]},"article-number":"37"}}